Integral Diagnostics Ltd. (IDX) Gets a Hold From Citi
Integral Diagnostics Raised to Buy From Neutral by Citigroup >IDX.AU
Loop Capital Markets Keeps Their Buy Rating on Integral Ad Science (IAS)
Integral Ad Science Is Maintained at Buy by Truist Securities
Integral Ad Science Price Target Raised to $17.00/Share From $16.00 by Truist Securities
Integral Ad Science Analyst Ratings
Scotiabank Maintains Sector Perform on Integral Ad Science, Raises Price Target to $12
Integral Ad Science (IAS) Gets a Buy From Craig-Hallum
Analysts Offer Insights on Communication Services Companies: Integral Ad Science (IAS), Liberty Media Liberty Formula One (FWONK) and Cable ONE (CABO)
Integral Ad Science: Strong Financial Performance and Strategic Positioning Drive Buy Rating
Truist Securities Adjusts Integral Ad Science Holding Price Target to $17 From $16, Maintains Buy Rating
Canaccord Genuity Upgrades Integral Diagnostics to Buy From Hold; Price Target Is AU$2.90
Bell Potter Sticks to Their Buy Rating for Integral Diagnostics Ltd. (IDX)
Integral Diagnostics Price Target Cut 7.4% to A$3.15/Share by Barrenjoey
Craig-Hallum Keeps Their Buy Rating on Integral Ad Science (IAS)
Compania De Distribucion Integral Logista Holdings (0QWA) Gets a Hold From Kepler Capital
RBC Capital Remains a Buy on Integral Diagnostics Ltd. (IDX)
Integral Diagnostics Price Target Raised 1.4% to A$3.50/Share by RBC Capital Markets
Analysts Are Bullish on Top Communication Services Stocks: Meta Platforms (META), Integral Ad Science (IAS)
Integral Ad Science (IAS) Receives a Hold From Barclays